| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.009 |